Industry News

You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.

Recordati sets out three-year growth plan
Premium

7 May 2021

Recordati plans to increase sales of its Procto-Glyvenol haemorrhoid treatment by more than a third by 2023 as part of a three-year plan which also includes developing new probiotic food supplements and acquisitions of OTC brands.

Read the full story

Futura’s MED3000 gains CE mark in Europe
Premium

3 May 2021

Futura Medical’s MED3000 topical gel for erectile dysfunction has now been certified as a Class IIb medical device in the European Union. The company told OTCToolbox it was "in discussions with a number of parties" about marketing and distribution rights.

Read the full story